Home Blog Style 22025-07-10T16:26:36-03:00

Avada includes a blog shortcode you can use anywhere on the site!

This blog shortcode was submitted by Markus, one of our Avada users and now on our developing team! It just goes to show what an awesome community we have, everyone is willing to help & share ideas. Dont wait, be a part of the Avada community today!

Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Rodolfo Chicas-Sett, Juan Zafra, Delvys Rodriguez-Abreu et al. Fuente: Int J Radiation Oncol Biol Phys, Vol. [...]

By |marzo 18th, 2025|Categories: Artículos recomendados, Presente de los tratamientos con Inmunoradioterapia|Comentarios desactivados en Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy

Lectura recomendada por el Lectura recomendada por el Dr. Santiago Fontes.  Conferencia 2024: “Inmunoterapia contra el cáncer; un nuevo paradigma” Autores: Tianyu Tang, Xing Huang, Gang Zhang, Zhengtao Hong, Xueli Bai and Tingbo Liang. Fuente: Signal [...]

By |marzo 18th, 2025|Categories: Artículos recomendados, Inmunoterapia contra el cáncer; un nuevo paradigma|Comentarios desactivados en Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy

Cancer immunotherapy: Pros, cons and beyond

Lectura recomendada por el Lectura recomendada por el Dr. Santiago Fontes.  Conferencia 2024: “Inmunoterapia contra el cáncer; un nuevo paradigma” Autores: Shuzhen Tana, Dongpei Lib, Xiao Zhu. Fuente: Biomedicine & Pharmacotherapy 124 (2020) Cancer immunotherapy: Pros, [...]

By |marzo 18th, 2025|Categories: Artículos recomendados, Inmunoterapia contra el cáncer; un nuevo paradigma|Comentarios desactivados en Cancer immunotherapy: Pros, cons and beyond
Ir a Arriba